Navigation Links
Stereotaxis Announces Election of Joseph D. Keegan to Board of Directors
Date:2/22/2011

ST. LOUIS, Feb. 22, 2011 /PRNewswire/ -- Stereotaxis, Inc. (Nasdaq: STXS) today announced that Joseph D. Keegan, Ph.D., 55, was elected to its Board of Directors.  Mr. Keegan is President and CEO of ForteBIO, Inc., a life science analytical instrument company.

Dr. Keegan has more than 25 years of experience managing high growth life science businesses.  Under Dr. Keegan's leadership, ForteBIO, Inc. has generated compounded annual revenue growth of 45% since his appointment to CEO in September 2007.  Prior to ForteBIO, Dr. Keegan was President and CEO of Molecular Devices Corporation (MDC) for nine years, during which time the company's revenues grew from $30 million to $190 million.  Dr. Keegan joined MDC from Becton Dickinson and Company, where he served as President of Worldwide Tissue Culture and Vice President, General Manager of Worldwide Flow Cytometry.  Prior to Becton Dickinson, Dr. Keegan was Vice President of the Microscopy and Scientific Instruments Division of Leica, Inc.  He currently serves on the Board of Directors of ALSSA as Vice Chairman, and Seahorse Bioscience Inc.  Dr. Keegan holds a Ph.D. in Physical Chemistry from Stanford University.

"We are very pleased to welcome Joseph Keegan to our board," said Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis.  "We believe Joe's strong executive experience and extensive knowledge of leading life science tools companies through their commercial adoption phase will be instrumental as we continue our efforts to establish both our Niobe robotic and Odyssey platforms as the standard of care within their respective markets."

About Stereotaxis             www.stereotaxis.com         www.
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Stereotaxis Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call
2. Stereotaxis Showcases Advancements for Remote Magnetic Ablations
3. China Cord Blood Corporation Announces Results of 2010 Annual General Meeting
4. Dendreon Announces Presentation of PROVENGE Data at the 2011 Genitourinary Cancers Symposium Annual Meeting
5. Sensus Healthcare Announces Its Exhibitor Attendance at the 9th Annual South Beach Symposium™
6. Sensus Healthcare Announces the Formation of a Medical Advisory Board
7. Sigma-Aldrich Announces Organizational Changes
8. Optimer Pharmaceuticals, Inc. Announces Exercise in Full of Underwriters Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
9. MiMedx Announces Launch of AmnioFix™
10. Savient Pharmaceuticals Announces Executive Appointments
11. Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera® (rituximab)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... UFP Technologies, a producer of innovative ... introduced a custom insulated shipping container to house ... insulated shipper solves the issue of temperature variations ... BioShell is a universal storage container which protects ... shipping. The insulated shipper keeps frozen BioShells within ...
(Date:9/30/2014)... 30, 2014 The International ... a non-profit organization based in Pittsburgh, Pennsylvania, and ... Safety (ACRES), a Massachusetts non-profit charitable organization, ... agreement, setting the stage for multiple collaborative projects. ... research quality and safety through specialized nursing practice ...
(Date:9/29/2014)... the military conflicts in Iraq and Afghanistan, more than ... traumatic brain injury caused by exposure to bomb blasts ... or IEDs. Symptoms of traumatic brain injury can range ... to more severe impairments in memory and cognition. ... recognized the critical importance and complexity of this problem, ...
(Date:9/29/2014)... , Sept. 29, 2014 /PRNewswire/ - Portage Biotech Inc. ... PBT.U), is pleased to announce that its three Promissory ... Portage, who advanced $ 100,000 each in July 2014 ... their Notes and related Coupons converted into 3,500,001 restricted ... carried 5% coupon. Both the Note and the coupon ...
Breaking Biology Technology:UFP Technologies Introduces Insulated Shipping Container For Bulk Drug Transportation 2UFP Technologies Introduces Insulated Shipping Container For Bulk Drug Transportation 3IACRN and ACRES to Support Clinical Research Nurses 2IACRN and ACRES to Support Clinical Research Nurses 3Modeling shockwaves through the brain 2Modeling shockwaves through the brain 3Modeling shockwaves through the brain 4Portage announces conversion of its debt into equity 2Portage announces conversion of its debt into equity 3
... Alba Therapeutics Corporation today,announced that its Investigational ... of endogenous insulin production capacity in new-onset,type 1 ... deliberation period,by the U.S. Food and Drug Administration ... study in 2008 while focusing the majority,of its ...
... will review common U.S. laws on research and process labs ... offer practical ... in association with Lab Manager Magazine, will present a Web,conference ... EST. The online conference will review common U.S. federal laws,pertaining ...
... SAN CARLOS, Calif., Sept. 5 NeurogesX, Inc.,(Nasdaq: ... developing novel,pain management therapies, announced today the appointment ... directors. Since May 2006, Mr. Peacock,has been a ... Prior to joining SV Life Sciences, Mr. Peacock ...
Cached Biology Technology:Alba Therapeutics Announces IND for Beta Cell Preservation in Type 1 Diabetes Using AT-1001 2Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies 2Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies 3NeurogesX Appoints New Director to the Board 2NeurogesX Appoints New Director to the Board 3
(Date:9/29/2014)... Energy Joint Genome Institute (DOE JGI), a DOE ... 32 new projects have been selected for the ... lakes to Caribbean waters, and from plant root ... in forested watersheds, the CSP 2015 projects portfolio ... be extracted. , "These projects catalyze JGI,s ...
(Date:9/29/2014)... anti-tumour activity in patients with advanced BRAF V600E ... progressed after chemotherapy, according to phase II data ... Spain. , "Reports of lung cancers bearing ... these mutations may be associated with increased sensitivity ... Dr David Planchard, pulmonary oncologist at the Gustav-Roussy ...
(Date:9/29/2014)... is here, and that means beer. And ... cold one, taking that first sip and ... reacted to form compounds that cause an ... why beers get skunky, and what you ... going bad. Learn all about it at ...
Breaking Biology News(10 mins):2015 DOE JGI's science portfolio delves deeper into the Earth's data mine 22015 DOE JGI's science portfolio delves deeper into the Earth's data mine 32015 DOE JGI's science portfolio delves deeper into the Earth's data mine 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 52015 DOE JGI's science portfolio delves deeper into the Earth's data mine 62015 DOE JGI's science portfolio delves deeper into the Earth's data mine 72015 DOE JGI's science portfolio delves deeper into the Earth's data mine 82015 DOE JGI's science portfolio delves deeper into the Earth's data mine 9Promising results shown with targeted approaches in subsets of non-small cell lung cancer 2Promising results shown with targeted approaches in subsets of non-small cell lung cancer 3
... steps have public officials in your state or community taken ... who are obese has tripled in just 35 years. Local ... it either easy or hard for families to find fresh ... and be physically active. LOCAL GOVERNMENT ACTIONS TO PREVENT CHILDHOOD ...
... at Virginia Tech, Harvard and Drexel finish studying the locomotion ... has a few new ways to increase his own world-breaking ... to maneuver in tight places, or to hover in one ... has researchers wondering if they can create smarter materials that ...
... Zurich, Switzerland, August 18, 2009 / b3c newswire ... that, following the successful completion of key research ... disease has advanced into preclinical development, triggering milestone ... (NASDAQ: BIIB). Neurimmune partnered with Biogen Idec for ...
Cached Biology News:Tackling childhood obesity at the local level -- IOM report releases Sept. 1 2NSF Emerging Frontiers' program supports development of smart materials based on study of fish 2NSF Emerging Frontiers' program supports development of smart materials based on study of fish 3Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 2Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development 3